|
|
|
In a move to transform the nation’s medical research capabilities and speed the movement of research discoveries from the bench to the bedside, National Institutes of Health (NIH) Director Elias A. Zerhouni, M.D., laid out a series of far-reaching initiatives known collectively as the NIH Roadmap for Medical Research.
Soon after becoming NIH Director in May 2002, Dr. Zerhouni convened a series of meetings to chart a “roadmap” for medical research in the 21st century — a process that identified major opportunities and gaps in biomedical research that no single institute at NIH could tackle alone, but that the agency still needed to address. Developed with input from more than 300 nationally recognized leaders in academia, industry, government and the public, the NIH Roadmap provides a framework of the strategic investments that NIH needs to make to optimize its entire research portfolio. The NIH Roadmap builds on the tremendous progress in medical research achieved, in part, through the recent doubling of the NIH budget. In setting forth an ambitious vision for a more efficient and productive system of medical research, the NIH Roadmap focuses on the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future and re-engineering the clinical research enterprise. Web site for the NIH Roadmap is located at:
http://nihroadmap.nih.gov
Message posted by: Rashmi Nemade
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|